|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality
Worldwide: IARC cancer base no. 11 [Internet]. Lyon, France;
International Agency for Research on Cancer; 2013, Available from:.
http://globocan.iarc.fr04
12–2017
|
|
3
|
John BA and Said N: Insights from animal
models of bladder cancer: Recent advances, challenges, and
opportunities. Oncotarget. 8:57766–57781. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kobayashi T, Owczarek TB, McKiernan JM and
Abate-Shen C: Modelling bladder cancer in mice: Opportunities and
challenges. Nat Rev Cancer. 15:42–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding J, Xu D, Pan C, Ye M, Kang J, Bai Q
and Qi J: Current animal models of bladder cancer: Awareness of
translatability (Review). Exp Ther Med. 8:691–699. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knapp DW, Glickman NW, Denicola DB, Bonney
PL, Lin TL and Glickman LT: Naturally-occurring canine transitional
cell carcinoma of the urinary bladder A relevant model of human
invasive bladder cancer. Urol Oncol. 5:47–59. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choy K and Fidel J: Tolerability and tumor
response of a novel low-dose palliative radiation therapy protocol
in dogs with transitional cell carcinoma of the bladder and
urethra. Vet Radiol Ultrasound. 57:341–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Knapp DW, Ruple-Czerniak A, Ramos-Vara JA,
Naughton JF, Fulkerson CM and Honkisz SI: A nonselective
cyclooxygenase inhibitor enhances the activity of vinblastine in a
naturally-occurring canine model of invasive urothelial carcinoma.
Bladder Cancer. 2:241–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arnold EJ, Childress MO, Fourez LM, Tan
KM, Stewart JC, Bonney PL and Knapp DW: Clinical trial of
vinblastine in dogs with transitional cell carcinoma of the urinary
bladder. J Vet Intern Med. 25:1385–1390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abbo AH, Jones DR, Masters AR, Stewart JC,
Fourez L and Knapp DW: Phase I clinical trial and pharmacokinetics
of intravesical mitomycin C in dogs with localized transitional
cell carcinoma of the urinary bladder. J Vet Intern Med.
24:1124–1130. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henry CJ, McCaw DL, Turnquist SE, Tyler
JW, Bravo L, Sheafor S, Straw RC, Dernell WS, Madewell BR,
Jorgensen L, et al: Clinical evaluation of mitoxantrone and
piroxicam in a canine model of human invasive urinary bladder
carcinoma. Clin Cancer Res. 9:906–911. 2003.PubMed/NCBI
|
|
12
|
Moch H, Humphrey PA, Ulbright TM and
Reuter VE: Tumours of the urinary tract. WHO Classification of
Tumours of the Urinary System and Male Genital Organs. 4th edition.
IARC; Lyon. pp; pp. 77–pp134. 2016
|
|
13
|
Humphrey PA, Moch H, Cubilla AL, Ulbright
TM and Reuter VE: The 2016 WHO Classification of Tumours of the
Urinary System and Male Genital Organs-Part B: Prostate and bladder
tumours. Eur Urol. 70:106–119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Knapp DW, Ramos-Vara JA, Moore GE, Dhawan
D, Bonney PL and Young KE: Urinary bladder cancer in dogs, a
naturally occurring model for cancer biology and drug development.
ILAR J. 55:100–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valli VE, Norris A, Jacobs RM, Laing E,
Withrow S, Macy D, Tomlinson J, McCaw D, Ogilvie GK, Pidgeon G, et
al: Pathology of canine bladder and urethral cancer and correlation
with tumour progression and survival. J Comp Pathol. 113:113–130.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patrick DJ, Fitzgerald SD, Sesterhenn IA,
Davis CJ and Kiupel M: Classification of canine urinary bladder
urothelial tumours based on the World Health
Organization/International Society of Urological Pathology
consensus classification. J Comp Pathol. 135:190–199. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Norris AM, Laing EJ, Valli VE, Withrow SJ,
Macy DW, Ogilvie GK, Tomlinson J, McCaw D, Pidgeon G and Jacobs RM:
Canine bladder and urethral tumors: A retrospective study of 115
cases (1980–1985). J Vet Intern Med. 6:145–153. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shapiro SG, Raghunath S, Williams C,
Motsinger-Reif AA, Cullen JM, Liu T, Albertson D, Ruvolo M,
Bergstrom Lucas A, Jin J, et al: Canine urothelial carcinoma:
Genomically aberrant and comparatively relevant. Chromosome Res.
23:311–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dhawan D, Paoloni M, Shukradas S,
Choudhury DR, Craig BA, Ramos-Vara JA, Hahn N, Bonney PL, Khanna C
and Knapp DW: Comparative gene expression analyses identify luminal
and basal subtypes of canine invasive urothelial carcinoma that
mimic patterns in human invasive bladder cancer. PLoS One.
10:e01366882015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Decker B, Parker HG, Dhawan D, Kwon EM,
Karlins E, Davis BW, Ramos-Vara JA, Bonney PL, McNiel EA, Knapp DW
and Ostrander EA: Homologous mutation to human BRAF V600E is common
in naturally occurring canine bladder cancer-evidence for a
relevant model system and urine-based diagnostic test. Mol Cancer
Res. 13:993–1002. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patronek GJ, Waters DJ and Glickman LT:
Comparative longevity of pet dogs and humans: Implications for
gerontology research. J Gerontol A Biol Sci Med Sci. 52:B171–B178.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dietrich K, Demidenko E, Schned A, Zens
MS, Heaney J and Karagas MR: Parity, early menopause and the
incidence of bladder cancer in women: A case-control study and
meta-analysis. Eur J Cancer. 47:592–599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prizment AE, Anderson KE, Harlow BL and
Folsom AR: Reproductive risk factors for incident bladder cancer:
Iowa Women's Health Study. Int J Cancer. 120:1093–1098. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kauffman EC, Robinson BD, Downes M,
Marcinkiewicz K, Vourganti S, Scherr DS, Gudas LJ and Mongan NP:
Estrogen receptor-β expression and pharmacological targeting in
bladder cancer. Oncol Rep. 30:131–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu
I, Izumi K, Chang C, Messing EM, Netto GJ and Yeh S: Expression of
androgen and oestrogen receptors and its prognostic significance in
urothelial neoplasm of the urinary bladder. BJU Int. 109:1716–1726.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tuygun C, Kankaya D, Imamoglu A, Sertcelik
A, Zengin K, Oktay M and Sertcelik N: Sex-specific hormone
receptors in urothelial carcinomas of the human urinary bladder: A
comparative analysis of clinicopathological features and survival
outcomes according to receptor expression. Urol Oncol. 29:43–51.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY,
Jian W, Sonpavde G, Ayala GE, Younes M and Lerner SP: Expression of
estrogen receptors-alpha and -beta in bladder cancer cell lines and
human bladder tumor tissue. Cancer. 106:2610–2616. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boorjian S, Ugras S, Mongan NP, Gudas LJ,
You X, Tickoo SK and Scherr DS: Androgen receptor expression is
inversely correlated with pathologic tumor stage in bladder cancer.
Urology. 64:383–388. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao GQ and Rashid H: Bladder neck
urothelial carcinoma: A urinary bladder subsite carcinoma with
distinct clinicopathology. Int J Surg Pathol. 23:517–523. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sciarra A, de Matteis A, Mariotti G, Voria
G, Lucera R and Di Silverio F: Histopathological aspects of
transitional cell carcinoma of the bladder: Analysis of 20 years
experience. Int J Urol. 11:467–475. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stephenson WT, Holmes FF, Noble MJ and
Gerald KB: Analysis of bladder carcinoma by subsite. Cystoscopic
location may have prognostic value. Cancer. 66:1630–1635. 1990.
|
|
32
|
Fulkerson CM and Knapp DW: Management of
transitional cell carcinoma of the urinary bladder in dogs: A
review. Vet J. 205:217–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo A, Liu A and Teng X: The pathology of
urinary bladder lesions with an inverted growth pattern. Chin J
Cancer Res. 28:107–121. 2016.PubMed/NCBI
|
|
34
|
Amin M: Histological variants of
urothelial carcinoma: Diagnostic, therapeutic and prognostic
implications. Mod Pathol. 2222. (Suppl 2): S96–S118. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhai QJ, Black J, Ayala AG and Ro JY:
Histologic variants of infiltrating urothelial carcinoma. Arch
Pathol Lab Med. 131:1244–1256. 2007.PubMed/NCBI
|
|
36
|
Madeb R and Messing EM: Gender, racial and
age differences in bladder cancer incidence and mortality. Urol
Oncol. 22:86–92. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yee DS, Ishill NM, Lowrance WT, Herr HW
and Elkin EB: Ethnic differences in bladder cancer survival.
Urology. 78:544–549. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee CT, Dunn RL, Williams C and Underwood
W III: Racial disparity in bladder cancer: Trends in tumor
presentation at diagnosis. J Urol. 176:927–933. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hankey BF and Myers MH: Black/white
differences in bladder cancer patient survival. J Chronic Dis.
40:65–73. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tracey E, Watt H, Currow D, Young J and
Armstrong B: Investigation of poorer bladder cancer survival in
women in NSW, Australia: A data linkage study. BJU Int.
113:437–448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
McGrath M, Michaud DS and de Vivo I:
Hormonal and reproductive factors and the risk of bladder cancer in
women. Am J Epidemiol. 163:236–244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Annan AC, Stevens KA and Osunkoya AO:
Urothelial carcinoma involving the ureteral orifice: A
clinicopathologic analysis of 93 cases. Hum Pathol. 65:101–106.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sui W, RoyChoudhury A, Wenske S, Decastro
GJ, McKiernan JM and Anderson CB: Outcomes and prognostic factors
of primary urethral cancer. Urology. 100:180–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou M, Netto GJ and Epstein JI:
Uropathology: Elsevier Saunders 1st Edition. 2012, View Article : Google Scholar
|
|
45
|
Dayyani F, Hoffman K, Eifel P, Guo C,
Vikram R, Pagliaro LC and Pettaway C: Management of advanced
primary urethral carcinomas. BJU Int. 114:25–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gakis G, Witjes JA, Compérat E, Cowan NC,
de Santis M, Lebret T, Ribal MJ and Sherif AM; European Association
of Urology: EAU guidelines on primary urethral carcinoma. Eur Urol.
64:823–830. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Svatek RS, Clinton TN, Wilson CA, Kamat
AM, Grossman HB, Dinney CP and Shah JB: Intravesical tumor
involvement of the trigone is associated with nodal metastasis in
patients undergoing radical cystectomy. Urology. 84:1147–1151.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kobayashi S, Fujii Y, Koga F, Yokoyama M,
Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H and Kihara K:
Impact of bladder neck involvement on progression in patients with
primary non-muscle invasive bladder cancer: A prospective
validation study. Urol Oncol. 32:38.e29–e36. 2014. View Article : Google Scholar
|
|
49
|
Reis LO, Ferreira F, Almeida M and
Ferreira U: Urethral carcinoma: Critical view on contemporary
consecutive series. Med Oncol. 28:1405–1410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Swartz MA, Porter MP, Lin DW and Weiss NS:
Incidence of primary urethral carcinoma in the United States.
Urology. 68:1164–1168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Terada T: Inverted variant of urothelial
carcinoma of the urinary bladder: A report of three cases and a
proposal for a new clinicopathologic entity. Int J Clin Ex Pathol.
6:766–770. 2013.
|
|
52
|
Kern WH: The grade and pathologic stage of
bladder cancer. Cancer. 53:1185–1189. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Babjuk M, Burger M, Zigeuner R, Shariat
SF, van Rhijn BW, Comperat E, Sylvester RJ, Kaasinen E, Böhle A,
Palou Redorta J, et al: EAU guidelines on non-muscle-invasive
urothelial carcinoma of the bladder: Update 2013. Eur Urol.
64:639–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mungan NA, Aben KK, Schoenberg MP, Visser
O, Coebergh JW, Witjes JA and Kiemeney LA: Gender differences in
stage-adjusted bladder cancer survival. Urology. 55:876–880. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Amin MB and Tickoo SK: Genitourinary
diagnostic pathology. IInd Edition. Elsevier; 2016
|
